title: Effects of activation of central nervous histamine receptors in cardiovascular regulation; studies in H(1) and H(2) receptor gene knockout mice.
abstract: To elucidate the central roles of histamine receptors in cardiovascular regulatory system, systolic, mean, and diastolic blood pressures (BPs) and heart rate (HR) were examined in conscious H(1) receptor gene knockout (H(1)KO) mice, H(2) receptor gene knockout (H(2)KO) mice, H(1) and H(2) receptor gene double knockout (DKO) mice, and their respective control mice by the tail-cuff system. Histamine, histamine-trifluoromethyl-toluidine derivative (HTMT, an H(1) agonist), dimaprit (an H(2) agonist), and immepip (an H(3) agonist) were intrathecally administered to these KO mice and control mice. Basal BPs and HR were not different among these three KO mice and their control or wild-type mice. Intrathecal administration of histamine significantly increased BPs and decreased HR in control mice. The increases in BPs were produced by histamine in H(1)KO and H(2)KO mice and by HTMT and dimaprit in C57BL mice. The pressor responses by HTMT and dimaprit in C57BL mice were greater than those by histamine in H(1)KO and H(2)KO mice, although the same decreases in HR were induced by histamine in C57BL and H(1)KO mice and by dimaprit in C57BL mice. The selective stimulation of H(3) receptors by immepip produced a consistent decrease in BPs in control mice. These results obtained with the exogenous selective agonists of three histamine receptors suggest that the pressor responses to histamine are mediated through the stimulation of both H(1) and H(2) receptors, whereas the atropine-sensitive decrease in heart rate is mainly due to H(2) receptors which activate the vagal output to the heart.
authors.affiliation: Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, Seiryo-machi 2-1, Aoba-ku, Sendai 980-8575, Japan.
authors.forename: Hideaki
authors.initials: H
authors.lastname: Suzuki
authors.forename: Jalal Izadi
authors.initials: JI
authors.lastname: Mobarakeh
authors.forename: Kazuo
authors.initials: K
authors.lastname: Nunoki
authors.forename: Jun
authors.initials: J
authors.lastname: Sukegawa
authors.forename: Haruo
authors.initials: H
authors.lastname: Watanabe
authors.forename: Atsuo
authors.initials: A
authors.lastname: Kuramasu
authors.forename: Takeshi
authors.initials: T
authors.lastname: Watanabe
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Yanai
authors.forename: Teruyuki
authors.initials: T
authors.lastname: Yanagisawa
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002490:Central Nervous System / Q000187:drug effects*; D017259:Dimaprit / Q000008:administration & dosage / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects*; D006632:Histamine / Q000008:administration & dosage / Q000494:pharmacology*; D017442:Histamine Agonists / Q000008:administration & dosage / Q000494:pharmacology*; D007093:Imidazoles / Q000008:administration & dosage / Q000494:pharmacology*; D007278:Injections, Spinal; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010880:Piperidines / Q000008:administration & dosage / Q000494:pharmacology*; D011968:Receptors, Histamine / Q000235:genetics*
chemical_list: D017442:Histamine Agonists; D007093:Imidazoles; D010880:Piperidines; D011968:Receptors, Histamine; C085755:4-(1H-imidazol-4-ylmethyl)piperidine; D006632:Histamine; D017259:Dimaprit
references.citation: J Pharmacol Exp Ther. 2003 Jun;305(3):1037-44
references.pmid: 12649305
references.citation: Neurosci Res. 1998 May;31(1):53-60
references.pmid: 9704978
references.citation: J Cardiovasc Pharmacol. 2003 Jan;41 Suppl 1:S127-31
references.pmid: 12688409
references.citation: J Cardiovasc Pharmacol. 2000;36 Suppl 2:S69-73
references.pmid: 11206725
references.citation: J Physiol Pharmacol. 1998 Jun;49(2):191-211
references.pmid: 9670104
references.citation: Inflamm Res. 2002 Nov;51(11):551-6
references.pmid: 12540019
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2004 Apr;369(4):418-27
references.pmid: 14991226
references.citation: J Biol Chem. 2003 Oct 31;278(44):43261-7
references.pmid: 12920136
references.citation: Neuroscience. 1987 Oct;23(1):149-57
references.pmid: 2446202
references.citation: Clin Exp Hypertens. 1978;1(2):251-65
references.pmid: 755650
references.citation: Physiol Rev. 1991 Jan;71(1):1-51
references.pmid: 1846044
references.citation: Neuroscience. 1998 Nov;87(2):479-87
references.pmid: 9740406
references.citation: J Clin Invest. 2000 Jun;105(12):1741-9
references.pmid: 10862789
references.citation: Nature. 1983 Apr 28;302(5911):832-7
references.pmid: 6188956
references.citation: Nat Rev Neurosci. 2003 Feb;4(2):121-30
references.pmid: 12563283
references.citation: Tohoku J Exp Med. 2001 Dec;195(4):197-217
references.pmid: 11908822
references.citation: Proc Natl Acad Sci U S A. 1984 Apr;81(8):2572-6
references.pmid: 6371818
references.citation: Can J Physiol Pharmacol. 1995 May;73(5):558-64
references.pmid: 7585321
references.citation: Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13316-20
references.pmid: 8917588
references.citation: Endocrinology. 1999 Aug;140(8):3713-9
references.pmid: 10433231
references.citation: J Pharmacol Exp Ther. 1989 Aug;250(2):500-7
references.pmid: 2569532
references.citation: Prog Neurobiol. 2001 Apr;63(6):637-72
references.pmid: 11164999
references.citation: Eur J Pharmacol. 1980 Oct 17;67(2-3):313-6
references.pmid: 6893963
references.citation: J Pharmacol Exp Ther. 1993 Feb;264(2):734-8
references.pmid: 8437121
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1976 May;293(2):151-7
references.pmid: 8735
references.citation: Hypertension. 1995 May;25(5):1111-5
references.pmid: 7737724
references.citation: J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):575-81
references.pmid: 6206309
references.citation: Mol Pharmacol. 2002 Aug;62(2):389-97
references.pmid: 12130692
references.citation: Eur J Pharmacol. 2000 Mar 10;391(1-2):81-9
references.pmid: 10720638
references.citation: Am J Physiol. 1995 Jul;269(1 Pt 2):H80-5
references.pmid: 7631878
references.citation: Neuropharmacology. 2002 Jun;42(8):1079-88
references.pmid: 12128009
references.citation: Brain Res. 1984 Mar 12;295(1):13-25
references.pmid: 6713171
references.citation: Fundam Clin Pharmacol. 1994;8(2):128-37
references.pmid: 8020871
references.citation: J Pharmacol Exp Ther. 2003 Jun;305(3):1212-21
references.pmid: 12626656
references.citation: Am J Physiol. 1993 Oct;265(4 Pt 2):H1149-54
references.pmid: 7902004
references.citation: J Pharmacol Exp Ther. 1981 Feb;216(2):315-20
references.pmid: 6450831
references.citation: Eur J Pharmacol. 2001 May 11;419(2-3):175-81
references.pmid: 11426839
references.citation: FEBS Lett. 2001 Jul 27;502(1-2):53-6
references.pmid: 11478947